Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations is a research paper published in Clinical Pharmacology & Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 44 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 099310/Z/12/Z
National Institutes of Health
Grant: U54HG003273
National Institutes of Health
Grant: U54HG006938
National Institutes of Health
Grant: 1U54AI110398
National Institutes of Health
Grant: U54HG006947
National Research Foundation
Grant: 128895
NIAID NIH HHS
Grant: U54 AI110398
NHGRI NIH HHS
Grant: UM1 HG008901
National Institutes of Health
Grant: 5U54HG006947-04
African Collaborative Center for Microbiome and Genomics Research (ACCME)
Wellcome Trust
Grant: 099310
TrypanoGEN: an integrated approach to the identification of genetic determinants of susceptibility to trypanosomiasis.
National Institutes of Health
Grant: 1U54AI110398-01A1
Collaborative African Genomics Network (CAFGEN)
National Institutes of Health
Grant: 5U54HG006938-09
AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans
National Institutes of Health
Grant: 3U54HG003273-04S1
Genomes and Genetics at the BCM-HGSC
National Institutes of Health
Grant: 3UM1HG008901-04S2
New York Center for Collaborative Research in Common Disease Genomics
GlaxoSmithKline
University of the Witwatersrand, Johannesburg
South African Medical Research Council
Wellcome Trust
FWCI
7.00
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’
Additional file 1 of A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’
Additional file 2 of A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’
Additional file 2 of A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’